Status:
WITHDRAWN
Insulin Infusion and Infectious Diabetic Foot Ulcers (IIIFU)
Lead Sponsor:
Karolinska Institutet
Conditions:
Diabetes Mellitus
Insulin Resistance
Eligibility:
All Genders
18+ years
Brief Summary
Normoglycemia is important for the outcome of surgical and medical conditions. Insulin infusions have been studied to achieve normoglycemia during these circumstances and have proved to be useful. Ins...
Detailed Description
Introduction: Normoglycemia is important for the outcome of acute surgical and medical conditions. Different insulin infusions have been studied to achieve normoglycemia and have proved to be useful....
Eligibility Criteria
Inclusion
- Patients are eligible for inclusion if the following criteria are fulfilled:
- Postoperative or infectious patients with: skin-, airways-, urine tract- or gastro-intestinal infections.
- Hyperglycaemia: Capillary P-glucose above 8 mmol/L.
- Older than 18 years.
- Informed consent obtained.
Exclusion
- Patients having any of the following at randomization will not be included in the study:
- Unconsciousness: not possible to wake up.
- Ketoacidosis: pH less or equal to 7.30.
- Hyperosmolar syndrome: S-Na more or equal to 150 mmol/L.
- Kidney failure: calculated GFR \< 30 mL/min.
- Pregnancy.
- Mental condition making the subject unable to understand the concepts and risk of the study.
Key Trial Info
Start Date :
December 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2016
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00700362
Start Date
December 1 2011
End Date
December 1 2016
Last Update
October 5 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Molecular Medicine and Surgery, Rolf Luft Research Center for Diabetes and Endocrinology
Stockholm, Sweden, 171 76